Devi SenGupta (@devisengupta3) 's Twitter Profile
Devi SenGupta

@devisengupta3

Infectious diseases MD, COVID-19 clinical trials, HIV cure research, clinical/translational immunology, drug development. All views are my own.

ID: 1234357788861554689

calendar_today02-03-2020 06:00:14

90 Tweet

133 Followers

118 Following

Devi SenGupta (@devisengupta3) 's Twitter Profile Photo

Hello Montreal and AIDS 2022! Can’t wait to reconnect with friends and colleagues this week. Excited for this session on Friday - critical discussion to have as the cure field expands!

Devi SenGupta (@devisengupta3) 's Twitter Profile Photo

It was an honor to be part of this panel discussing how we can advance #hivcure research in LMIC at IAC - the International AIDS Conference ! We can do it…with commitment, resilience and collaboration!

IAS - the International AIDS Society (@iasociety) 's Twitter Profile Photo

The IAS-hosted satellite session, ā€œAfrica #HIV cure research: Strengthening industry-community engagement in clinical researchā€, is now underway at #AIDS2022. Delegates take part in Room 524 or virtually on Channel programme.aids2022.org/Programme/Sess…

The IAS-hosted satellite session, ā€œAfrica #HIV cure research: Strengthening industry-community engagement in clinical researchā€, is now underway at #AIDS2022. 

Delegates take part in Room 524 or virtually on Channel programme.aids2022.org/Programme/Sess…
Gilead Sciences (@gileadsciences) 's Twitter Profile Photo

At #AIDS2022, let’s talk diversity. #HIV clinical research is more impactful when everyone is included — and that's why we take a conscious, thoughtful approach to building clinical trials in which a diverse range of people who would benefit from PrEP are represented.

Gilead Sciences (@gileadsciences) 's Twitter Profile Photo

As #AIDS2022 wraps up, we’re reflecting on the progress made toward the ultimate goal of finding a functional cure for #HIV. We’re working to achieve that goal through collaboration and innovation.

Devi SenGupta (@devisengupta3) 's Twitter Profile Photo

Thank you to the IAS - the International AIDS Society Industry collaborative group for organizing an excellent discussion on #communityengagement in #hivcure. Science is better when everyone is at the table!

Gilead Sciences (@gileadsciences) 's Twitter Profile Photo

Today, we announced the first global regulatory approval of the only twice-yearly #HIV treatment option. Learn more. gilead.inc/3AdjAjB

Today, we announced the first global regulatory approval of the only twice-yearly #HIV treatment option. Learn more. gilead.inc/3AdjAjB
UNAIDS Global (@unaids) 's Twitter Profile Photo

Not to be missed! Join Eamonn Murphy, Hank Tomlinson, Larkin Callaghan, Marc Thompson, Antons Mozalevskis and USAmbPEPFAR for an important discussion about what #monkeypox means for people living with HIV and key populations. More info and register šŸ‘‡šŸ¾

Devi SenGupta (@devisengupta3) 's Twitter Profile Photo

Amazing work by our HIV treatment team…I have witnessed firsthand the tireless commitment of my colleagues who brought Lenacapavir across the finish line. PLWH deserve the best options across treatment, prevention and (someday) cure!

Mallar Bhattacharya (@mallarbhattach1) 's Twitter Profile Photo

Interested in a postdoc in lung biology? My lab is hiring a postdoctoral fellow! Find us at bhattacharyalab.ucsf.edu or DM me. UCSF School of Medicine ATS_RCMB #Immunology #scRNAseq #Lung #postdocjobs #postdocposition

Interested in a postdoc in lung biology? My lab is hiring a postdoctoral fellow! Find us at bhattacharyalab.ucsf.edu or DM me. <a href="/UCSFMedicine/">UCSF School of Medicine</a> <a href="/ATS_RCMB/">ATS_RCMB</a> #Immunology #scRNAseq #Lung #postdocjobs #postdocposition
Devi SenGupta (@devisengupta3) 's Twitter Profile Photo

It’s been an energizing day at #CROI2023 !!! Exciting data from the Gilead team and our partners as we push #HIVcure research forward.

Devi SenGupta (@devisengupta3) 's Twitter Profile Photo

Wonderful to be on panel with Australian HIV community advocates and clinicians yesterday, discussing HIV cure clinical trial engagement. #IAS2023 #hivcure Gilead Sciences #innovationandinclusion